Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917240 · ClinicalTrials.gov registry record · Phase 4
Sequential vs. Monophasic Media Impact Trial (SuMMIT)
A Phase 4 study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT01917240: Completed Phase 4 study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT01917240 is a Phase 4 study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 200 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01917240, a Phase 4 study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
To evaluate the impact of two FDA approved culture media on potential of human embryos resulting from IVF (sequential \& monophasic media). Half of each patient's embryos will be randomly assigned to grow in monophasic media \& the other half in sequential media. All embryos will undergo Comprehensive Chromosome Screening (CCS) \& the best euploid embryo from each group will be transferred resulting in a double embryo transfer (DET). If there are only euploid embryos from one group, patient will have single embryo transfer (SET)(fresh or frozen).
Primary Outcome
To assess if pregnancy rates are impacted by the type of culture media embryos produced by IVF are cultured in
Interventions
- OTHER Comprehensive Chromosome Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
What the finished NCT01917240 record still lists
NCT01917240 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 1 intervention - of which Comprehensive Chromosome Screening is the first listed.
NCT01917240 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01917240 about?
NCT01917240 is a clinical study titled "Sequential vs. Monophasic Media Impact Trial (SuMMIT)". To evaluate the impact of two FDA approved culture media on potential of human embryos resulting from IVF (sequential \& monophasic media). Half of each patient's embryos will be randomly assigned to grow in monophasic media \& the other half in sequential media. All embryos will undergo Comprehensi...
What is the current status of trial NCT01917240?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2013-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01917240?
The interventions under investigation include: Comprehensive Chromosome Screening (OTHER).
Who is sponsoring clinical trial NCT01917240?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01917240's enrollment target sits among peer trials
200 407th of 2000 higher than 1,556 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia